Jiangsu Cowin Biotech Co., Ltd. logo

Jiangsu Cowin Biotech Co., Ltd. (688426)

Market Closed
11 Aug, 06:57
SSE SSE
¥
19. 54
-0.01
-0.0512%
¥
2.8B Market Cap
- P/E Ratio
2.08% Div Yield
1.64M Volume
- Eps
¥ 19.55
Previous Close
Add Transaction
Day Range
18.85 19.83
Year Range
14.42 33.67
Want to track 688426 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688426 closed today lower at ¥19.54, a decrease of -0.0512% from yesterday's close, completing a monthly increase of 7.6584% or ¥1.39. Over the past 12 months, 688426 stock lost -18.5833%.
688426 is not paying dividends to its shareholders.
The last earnings report, released on Oct 29, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Jiangsu Cowin Biotech Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 12, 2023.
The company's stock is traded on one exchange.

688426 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Jiangsu Cowin Biotech Co., Ltd. (688426) FAQ

What is the stock price today?

The current price is ¥19.54.

On which exchange is it traded?

Jiangsu Cowin Biotech Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688426.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.08%.

What is its market cap?

As of today, the market cap is 2.8B.

Has Jiangsu Cowin Biotech Co., Ltd. ever had a stock split?

Jiangsu Cowin Biotech Co., Ltd. had 1 splits and the recent split was on Jun 12, 2023.

Jiangsu Cowin Biotech Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Chaofeng Hao CEO
SSE Exchange
CNE100005NM2 ISIN
CN Country
657 Employees
12 Jun 2023 Last Dividend
12 Jun 2023 Last Split
- IPO Date

Overview

Jiangsu CoWin Biotech Co., Ltd. is a prominent entity in China's biotechnology sector, focusing on the research and development, manufacture, and commercialization of a wide range of biological products. Founded in 2010, the company has quickly established itself as a key player in the field, primarily catering to the burgeoning needs of molecular diagnostics and medical device products. With its headquarters in Taizhou, China, Jiangsu CoWin Biotech has dedicated itself to advancing the science of molecular diagnostics through innovative solutions and services, contributing significantly to the healthcare and scientific research industries domestically.

Products and Services

Jiangsu CoWin Biotech Co., Ltd. offers an extensive portfolio of products and services designed to meet the diverse needs of the healthcare and scientific research sectors:

  • Molecular Diagnostic Raw Material Enzymes: These enzymes are essential for the accuracy and efficiency of molecular diagnostic tests, helping in the amplification and detection of nucleic acids.
  • Nucleic Acid Collection and Protection Agents: These agents are crucial for stabilizing and preserving the integrity of nucleic acids from the point of collection until analysis, ensuring reliable results in diagnostic procedures.
  • Nucleic Acid Extraction and Purification Kits: These kits are designed to efficiently isolate and purify nucleic acids from a variety of biological samples, facilitating downstream molecular analyses.
  • Molecular Diagnostic Testing Reagents: These reagents are key components for conducting molecular diagnostic tests, including those for infectious diseases, genetic disorders, and cancer.
  • Medical Device Products: The company also provides a range of medical devices that support the collection, preservation, and analysis of biological samples.
  • PCR, RT-PCR, and qPCR Products: These products are essential for the amplification of DNA and RNA, enabling the detection and quantification of specific nucleic acid sequences in research and diagnostic applications.
  • Molecular Diagnosis: Offering comprehensive solutions for molecular diagnostic testing, including platforms and reagents for detecting and analyzing genetic material.
  • Isothermal Amplification: This technology allows for the rapid and sensitive amplification of nucleic acids at a constant temperature, simplifying the diagnostic process.
  • Nucleic Acid Mass Spectrometry: This advanced technique is used for the precise quantification and sequencing of nucleic acids, supporting genomics research and diagnostics.
  • Next Generation Sequencing: Providing services and products for high-throughput sequencing, enabling detailed genetic analysis and research.
  • Nucleic Acid Extraction and Purification: Beyond kits, this encompasses a comprehensive range of solutions tailored for extracting and purifying nucleic acids from complex samples with high yield and purity.
  • Marker Clone Transfection: Offering tools and reagents for the introduction of DNA into cells, facilitating gene expression studies and the development of gene therapies.
  • Antibody and Protein Detection Products: These products are vital for the investigation and quantification of proteins and antibodies, playing a crucial role in research and diagnostic assays.
  • Scientific Research Instruments: Jiangsu CoWin Biotech also supplies a variety of instruments and equipment designed to support the scientific research community in conducting advanced experiments and analyses.

Contact Information

Address: No. 18, Zelan Road, Taizhou, China, 225311
Phone: 86 523 8620 1353